MTOR and pulmonary fibrosis: Dysregulation of mTOR signaling in the lungs results in different pathologies, such as idiopathic pulmonary fibrosis, COPD, pulmonary hypertension, lymphangioleiomyomatosis and other lung cancers [93–96].